Bibliography

  1. Nusslein-Volhard, C. and E. Wieschaus, Mutations affecting segment number and polarity in Drosophila. Nature, 1980. 287: p. 795-801.
  2. Kuwabara, P.E., Worming your way through the genome. Trends Genet, 1997. 13(11): p. 455-460.
  3. Haffter, P., et al., The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development, 1996. 123: p. 1-36.
  4. Driever, W., et al., A genetic screen for mutations affecting embryogenesis in zebrafish. Development, 1996. 123: p. 37-46.
  5. Woychik, R.P., et al., Functional genomics in the post-genome era [published erratum appears in Mutat Res 1998 Dec 3;422(2):367]. Mutat Res, 1998. 400(1-2): p. 3-14.
  6. Schimenti, J. and M. Bucan, Functional genomics in the mouse: phenotype-based mutagenesis screens. Genome Res, 1998. 8(7): p. 698-710.
  7. Hrabe de Angelis, M. and R. Balling, Large scale ENU screens in the mouse: genetics meets genomics. Mutat Res, 1998. 400(1-2): p. 25-32.
  8. Brown, S.D. and P.M. Nolan, Mouse mutagenesis-systematic studies of mammalian gene function. Hum Mol Genet, 1998. 7(10): p. 1627-33.
  9. Justice, M.J., et al., Using targeted large deletions and high-efficiency N-ethyl-N- nitrosourea mutagenesis for functional analyses of the mammalian genome. Methods, 1997. 13(4): p. 423-36.
  10. Shedlovsky, A., et al., Mouse models of human phenylketonuria. Genetics, 1993. 134(4): p. 1205-1210.
  11. Hitotsumachi, S., D.A. Carpenter, and W.L. Russell, Dose-repetition increases the mutagenic effectiveness of N-ethyl-N- nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A, 1985. 82(19): p. 6619-21.
  12. Rinchik, E.M. and D.A. Carpenter, N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah- Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics, 1999. 152(1): p. 373-383.
  13. Brown, S.D. and J. Peters, Combining mutagenesis and genomics in the mouse--closing the phenotype gap. Trends Genet, 1996. 12(11): p. 433-5.
  14. Kasarskis, A., K. Manova, and K.V. Anderson, A phenotype-based screen for embryonic lethal mutations in the mouse. Proc Natl Acad Sci U S A, 1998. 95(13): p. 7485-90.
  15. Rinchik, E.M. and L.B. Russell, Germ-line deletion mutations in the mouse: tools for intensive functional and physical mapping of regions of the mammalian genome. In: Genome Analysis, Vol. 1: Genetic and Physical Mapping. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1990: p. 121-158.
  16. Klungland, A., et al., Spectrum of mutations induced by methyl and ethyl methanesulfonate at the hprt locus of normal and tag expressing Chinese hamster fibroblasts. Carcinogenesis, 1995. 16(6): p. 1281-5.
  17. Morgan, T.L., et al., Molecular characterization of X-ray-induced mutations at the HPRT locus in plateau-phase Chinese hamster ovary cells. Mutat Res, 1990. 232(2): p. 171-82.
  18. Vrieling, H., et al., Mutations induced by X-rays at the HPRT locus in cultured Chinese hamster cells are mostly large deletions. Mutat Res, 1985. 144(4): p. 281-6.
  19. Urlaub, G., et al., Effect of gamma rays at the dihydrofolate reductase locus: deletions and inversions. Somat Cell Mol Genet, 1986. 12(6): p. 555-66.
  20. Grosovsky, A.J., et al., Southern analysis of genomic alterations in gamma-ray-induced aprt- hamster cell mutants. Genetics, 1986. 113(2): p. 405-15.
  21. Miles, C., et al., DNA sequence analysis of gamma radiation-induced deletions and insertions at the APRT locus of hamster cells. Mol Carcinog, 1990. 3(4): p. 233-42.
  22. Kronenberg, A. and J.B. Little, Molecular characterization of thymidine kinase mutants of human cells induced by densely ionizing radiation. Mutat Res, 1989. 211(2): p. 215-24.
  23. Battey, J., et al., An Action Plan for Mouse Genomics. Nature Genetics, 1999. 21: p. 73-75.
  24. Russell, W.L., et al., Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci U S A, 1979. 76(11): p. 5818-5819.
  25. Hsie, A.W., et al., The dose-response relationship for ethyl methanesulfonate-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells. Somatic Cell Genet, 1975. 1(3): p. 247-61.
  26. Zheng, B., et al., Engineering a mouse balancer chromosome. Nat Genet, 1999. 22(4): p. 375-378.
  27. Ramirez-Solis, R., P. Liu, and A. Bradley, Chromosome engineering in mice. Nature, 1995. 378(6558): p. 720-4.
  28. You, Y., et al., Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nat Genet, 1997. 15(3): p. 285-8.
  29. Thomas, J.W., C. LaMantia, and T. Magnuson, X-ray-induced mutations in mouse embryonic stem cells. Proc Natl Acad Sci U S A, 1998. 95(3): p. 1114-9.
  30. Kucera, G.T., D.M. Bortner, and M.P. Rosenberg, Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev Biol, 1996. 173(1): p. 162-173.
  31. Okabe, M., et al., 'Green mice' as a source of ubiquitous green cells. FEBS Lett, 1997. 407(3): p. 313-9.
  32. Hadjantonakis, A.K., et al., Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev, 1998. 76(1-2): p. 79-90.
  33. O'Brien, T.P., et al., Complementation mapping of skeletal and central nervous system abnormalities in mice of the piebald deletion complex. Genetics, 1996. 143(1): p. 447-61.
  34. Delbank: http://lena.jax.org/~jcs/Delbank.html.
  35. Berger, H., W.J. Brammar, and C. Yanofsky, Spontaneous and ICR191-A-induced frameshift mutations in the A gene of Escherichia coli tryptophan synthetase. J Bacteriol, 1968. 96: p. 1672-9.
  36. Taylor, B.A., L. Rowe, and D.A. Grieco, The MEV mouse linkage testing stock: mapping 30 novel proviral insertions and establishment of an improved stock. Genomics, 1993. 16: p. 380-394.
  37. Rogers, D.C., et al., Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome, 1997. 8(10): p. 711-3.
  38. Irwin, S., Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia, 1968. 13: p. 222-57.
  39. SHIRPA protocol summary: http://www.mgc.har.mrc.ac.uk/mutabase/shirpa_summary.html.
  40. Reeves, R.H., et al., A mouse model for Down syndrome exhibits learning and behaviour deficits [see comments]. Nat Genet, 1995. 11(2): p. 177-84.
  41. Drago, J., et al., Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev Neurosci, 1998. 20(2-3): p. 188-203.
  42. Mokhtarian, A., et al., Components of energy expenditure in the mdx mouse model of Duchenne muscular dystrophy. Pflugers Arch, 1996. 431(4): p. 527-32.
  43. Naggert, J., T. Harris, and M. North, The genetics of obesity. Curr Opin Genet Dev, 1997. 7(3): p. 398-404.
  44. Woods, S.C. and E.M. Stricker, Food Intake and Metabolism. 1999, San Diego: Academic Press.
  45. Levin, B.E. and V.H. Routh, Role of the brain in energy balance and obesity [editorial]. Am J Physiol, 1996. 271(3 Pt 2): p. R491-500.
  46. Naggert, J.K. and P.M. Nishina, Mouse models of obesity. Curr Opin Endocrinol Diabetes, 1995. 2: p. 513-517.
  47. Lyon, M.F. and A.G. Searle, Genetic Variants and Strains of the Laboratory Mouse. 3 ed. Vol. 1. 1996, Oxford: Oxford University Press.
  48. Allison, D.B., et al., Multiple phenotype modeling in gene-mapping studies of quantitative traits: power advantages. Am J Hum Genet, 1998. 63(4): p. 1190-201.
  49. Perusse, L., et al., The human obesity gene map: the 1998 update. Obes Res, 1999. 7(1): p. 111-29.
  50. West, D.B., et al., Genetics of dietary obesity in AKR/J x SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4. Mamm Genome, 1994. 5(9): p. 546-52.
  51. Katafuchi, T., et al., Involvement of angiotensin II in water intake of genetically polydipsic mice. Am J Physiol, 1991. 260(6 Pt 2): p. R1152-8.
  52. Kutscher, C.L., Strain differences in drinking in inbred mice during ad libitum feeding and food deprivation. Physiol Behav, 1974. 13(1): p. 63-70.
  53. DeFries, J.C., M.C. Gervais, and E.A. Thomas, Response to 30 generations of selection for open-field activity in laboratory mice. Behav Genet, 1978. 8(1): p. 3-13.
  54. Pennycuik, P.R., A comparison of the effects of a variety of factors on the metabolic rate of the mouse. Aust J Exp Biol Med Sci, 1967. 45(4): p. 331-46.
  55. Gershenfeld, H.K., et al., Mapping quantitative trait loci for open-field behavior in mice. Behav Genet, 1997. 27(3): p. 201-10.
  56. Smith, B.K., D.B. West, and D.A. York, Carbohydrate versus fat intake: differing patterns of macronutrient selection in two inbred mouse strains. Am J Physiol, 1997. 272(1 Pt 2): p. R357-62.
  57. Reed, D.R., et al., Heritable variation in food preferences and their contribution to obesity. Behav Genet, 1997. 27(4): p. 373-87.
  58. Bachmanov, A.A., M.G. Tordoff, and G.K. Beauchamp, Voluntary sodium chloride consumption by mice: differences among five inbred strains. Behav Genet, 1998. 28(2): p. 117-24.
  59. Beauchamp, G.K., A. Bachmanov, and L.J. Stein, Development and genetics of glutamate taste preference. Ann N Y Acad Sci, 1998. 855: p. 412-6.
  60. Cooper, S.J. and R.L. Francis, Food-choice in a food-preference test: comparison of two mouse strains and the effects of chlordiazepoxide treatment. Psychopharmacology (Berl), 1979. 65(1): p. 89-93.
  61. Collins, S., et al., Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology, 1997. 138(1): p. 405-13.
  62. Thomas, S.A. and R.D. Palmiter, Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline [see comments]. Nature, 1997. 387(6628): p. 94-7.
  63. Pedrazzini, T., et al., Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor [see comments]. Nat Med, 1998. 4(6): p. 722-6.
  64. Elmquist, J.K., C.F. Elias, and C.B. Saper, From lesions to leptin: hypothalamic control of food intake and body weight. Neuron, 1999. 22(2): p. 221-32.
  65. Fisher, S.L., K.A. Yagaloff, and P. Burn, Melanocortin-4 receptor: a novel signalling pathway involved in body weight regulation. Int J Obes Relat Metab Disord, 1999. 23 Suppl 1: p. 54-8.
  66. Friedman, J.M., R.L. Leibel, and N. Bahary, Molecular mapping of obesity genes. Mamm Genome, 1991. 1(3): p. 130-44.
  67. Leibel, R.L., N. Bahary, and J.M. Friedman, Strategies for the molecular genetic analysis of obesity in humans. Crit Rev Food Sci Nutr, 1993. 33(4-5): p. 351-8.
  68. Wise, R.A., Drug-activation of brain reward pathways. Drug Alcohol Depend, 1998. 51(1-2): p. 13-22.
  69. Vitaterna, M.H., et al., Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science, 1994. 264(5159): p. 719-725.
  70. George, F.R. and M.C. Ritz, Cocaine produces locomotor stimulation in SS but not LS mice: relationship to dopaminergic function. Psychopharmacology, 1990. 101(1): p. 18-22.
  71. Murray, P.D., et al., Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci, 1998. 18(18): p. 7306-14.
  72. Hall, E.D., et al., Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res, 1998. 53(1): p. 66-77.
  73. Desai, K.H., et al., Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease. Am J Physiol, 1997. 272(2 Pt 2): p. H1053-61.
  74. Noben-Trauth, K., et al., A candidate gene for the mouse mutation tubby. Nature, 1996. 380(6574): p. 534-8.
  75. Sahly, I., et al., Prominent neuronal-specific tub gene expression in cellular targets of tubby mice mutation. Hum Mol Genet, 1998. 7(9): p. 1437-47.
  76. Coleman, D.L. and E.M. Eicher, Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered, 1990. 81(6): p. 424-7.
  77. Hikosaka, O., Basal ganglia--possible role in motor coordination and learning. Curr Opin Neurobiol, 1991. 1(4): p. 638-43.
  78. Mink, J.W. and W.T. Thach, Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol, 1993. 3(6): p. 950-7.
  79. Hultborn, H., et al., How do we approach the locomotor network in the mammalian spinal cord? Ann N Y Acad Sci, 1998. 860: p. 70-82.
  80. Berciano, J., Olivopontocerebellar atrophy, in Parkinson's Disease and Movement Disorders, J. Jankovic and E. Tolosa, Editors. 1993, Williams & Wilkins: Baltimore. p. 163-189.
  81. Lechtenberg, R., Ataxia and other cerebellar syndromes, in Parkinson's Disease and Movement Disorders, J. Jankovic and E. Tolosa, Editors. 1993, Williams & Wilkins: Baltimore. p. 419-431.
  82. Steinlin, M., Non-progressive congenital ataxias. Brain Dev., 1998. 20(4): p. 199-208.
  83. Goldowitz, D. and K. Hamre, The cells and molecules that make a cerebellum. TINS, 1998. 21: p. 375-382.
  84. Cox, G.A., et al., Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice [published erratum appears in Cell 1997 Dec 12;91(6):861]. Cell, 1997. 91(1): p. 139-48.
  85. Cummings, C.J., H.T. Orr, and H.Y. Zoghbi, Progress in pathogenesis studies of spinocerebellar ataxia type 1. Philosophical Transactions of the Royal Society of London, 1999. 354: p. 1079-1081.
  86. Raeber, A.J., et al., Transgenic and knockout mice in research on prion diseases. Brain Pathology, 1998. 8(October): p. 715-733.
  87. Pennacchio, L.A., et al., Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet., 1998. 20(3): p. 251-258.
  88. Emery, A.E.H., Neuromuscular disorders : clinical and molecular genetics. 1998, Chichester ; New York: J. Wiley. xxiii, 563.
  89. Siddique, T. and H.X. Deng, Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet., 1996: p. 1465-1470.
  90. Muscular Dystrophy Association: http://www.mdausa.org.
  91. Cox, G.A., C.L. Mahaffey, and W.N. Frankel, Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron, 1998. 21(6): p. 1327-37.
  92. Cook, S.A., et al., Neuromuscular degeneration (nmd): a mutation on mouse chromosome 19 that causes motor neuron degeneration. Mamm. Genome, 1995. 6: p. 187-191.
  93. Bronson, R.T., et al., Genetic and age related models of neurodegeneration in mice: dystrophic axons. J. Neurogenet., 1992. 8(2): p. 71-83.
  94. Lane, P.W., T.C. Beamer, and D.D. Myers, Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered, 1976. 67(3): p. 135-8.
  95. Lane, P.W., Muscular dystrophy with myositis (mdm). Mouse News Letter, 1985. 73: p. 18.
  96. Michelson, A.M., E.S. Russell, and P.J. Harman, Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. USA, 1955. 41: p. 1079-1084.
  97. Bronson, R.T., et al., Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann. Neurol., 1993. 33: p. 381-385.
  98. Messer, A., et al., Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of Amyotrophic Lateral Sclerosis (ALS). Genomics, 1992. 13: p. 797-802.
  99. Sicinski, P., et al., The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 1989. 244(4912): p. 1578-1580.
  100. Cox, G.A., et al., Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy [see comments]. Nat Genet, 1994. 8(4): p. 333-9.
  101. Cox, G.A., et al., New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nature Genetics, 1993. 4(1): p. 87-93.
  102. Cox, G.A., et al., Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature, 1993. 364(6439): p. 725-9.
  103. Hauser, M.A., et al., Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy. Neuromuscul Disord, 1997. 7(5): p. 277-83.
  104. Cook, S.A., et al., Cerebellar deficient folia (cdf): a new mutation on mouse chromosome 6. Mamm. Genome, 1997. 8(2): p. 108-112.
  105. Costa, A., K. Walsh, and M. Davisson, Motor dysfunction in a mouse model for down syndrome. Physiology & Behavior, 1999.
  106. Sunada, Y., et al., Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet, 1995. 4(6): p. 1055-61.
  107. Gurney, M.E., et al., Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 1994. 264(5166): p. 1772-1775.
  108. Goldowitz, D., D. Wahlsten, and R.E. Wimer, Techniques for the Genetic Analysis of Brain and Behavior. Techniques in the Behavioral and Neural Sciences, ed. J. Huston. Vol. 8. 1992, Amsterdam: Elsevier Science Publishers BV. 530.
  109. McGavern, D., et al., Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Experimental Neurology, 1999. 158: p. 171-181.
  110. Ackerman, S.L., et al., The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature, 1997. 386: p. 838-42.
  111. Leonardo, E.D., et al., Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature, 1997. 386(6627): p. 833-838.
  112. Przyborski, S.A., B.B. Knowles, and S.L. Ackerman, Embryonic phenotype of Unc5h3 mutant mice suggests chemorepulsion during the formation of the rostral cerebellar boundary. Development, 1998. 125(1): p. 41-50.
  113. Hayes, A. and D.A. Williams, Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol. J Neurol Sci, 1998. 157(2): p. 122-8.
  114. Hayes, A. and D.A. Williams, Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol, 1998. 274(4 Pt 1): p. C1138-44.
  115. Hayes, A. and D.A. Williams, Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol, 1994. 21(10): p. 757-65.
  116. Rezvani, M., E. Cafarelli, and D.A. Hood, Performance and excitability of mdx mouse muscle at 2, 5, and 13 wk of age. J Appl Physiol, 1995. 78(3): p. 961-7.
  117. Hollingworth, S., M.W. Marshall, and E. Robson, Excitation contraction coupling in normal and mdx mice. Muscle Nerve, 1990. 13(1): p. 16-20.
  118. Dupont-Versteegden, E.E., Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. J Appl Physiol, 1996. 80(3): p. 734-41.
  119. Pastoret, C. and A. Sebille, Time course study of the isometric contractile properties of mdx mouse striated muscles. J Muscle Res Cell Motil, 1993. 14(4): p. 423-31.
  120. Anderson, J.E., B.H. Bressler, and W.K. Ovalle, Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil, 1988. 9(6): p. 499-515.
  121. Soucy, M., K. Seburn, and P. Gardiner, Is increased voluntary motor activity beneficial or detrimental during the period of motor nerve regeneration/reinnervation? Can J Appl Physiol, 1996. 21(3): p. 218-24.
  122. Seburn, K.L. and P. Gardiner, Adaptations of rat lateral gastrocnemius motor units in response to voluntary running. J Appl Physiol, 1995. 78: p. 1673-8.
  123. Seburn, K.L. and P.F. Gardiner, Properties of sprouted rat motor units: effects of period of enlargement and activity level. Muscle Nerve, 1996. 19(9): p. 1100-9.
  124. Hood, D.A. and G. Parent, Metabolic and contractile responses of rat fast-twitch muscle to 10-Hz stimulation. Am J Physiol, 1991. 260(4 Pt 1): p. C832-40.
  125. Anderson, V.E., W.A. Hauser, and S.S. Rich, Genetic heterogeneity and epidemiology of the epilepsies, in Jasper's Basic Mechanisms of the Epilepsies, A.V. Delgado-Escueta, et al., Editors. 1999, Lippincott Williams & Wilkens: Philadelphia.
  126. Charlier, C., et al., A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family [see comments]. Nat Genet, 1998. 18(1): p. 53-5.
  127. Singh, N.A., et al., A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns [see comments]. Nat Genet, 1998. 18(1): p. 25-9.
  128. Ottman, R., et al., Segregation analysis of cryptogenic epilepsy and an empirical test of the validity of the results. Am J Hum Genet, 1997. 60(3): p. 667-75.
  129. van Rijckevorsel, K.L., L. Debrabandere, and W. Deberdt, Evaluation of the efficacy and tolerability of UCB L059 in refractory epileptic patients with complex partial seizures: a 12-week, single-blind, add-on, rising-dose study. Epilepsia, 1996. 37(Suppl 5): p. 169.
  130. Loscher, W. and D. Honack, Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol, 1993. 232(2-3): p. 147-58.
  131. Klitgaard, H., et al., Levetiracetam (UCB L059) prevents limbic seizures induced by pilocarpine and kainic acid in rats. Epilepsia, 1996. 37(Suppl 5): p. 118.
  132. Barton, M.E., H.H. Wolf, and H.S. White, Characterization of a phenytoin-resistant mouse seizure model. Soc Neurosci Abstr, 1999. 25(1): p. 1115.
  133. Noebels, J.L., Single locus mutations in mice expressing generalized spike-wave absence epilepsies. Ital J Neurol Sci, 1995. 16(1-2): p. 107-11.
  134. Burgess, D.L., et al., Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell, 1997. 88(3): p. 385-92.
  135. Fletcher, C.F., et al., Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell, 1996. 87(4): p. 607-17.
  136. Letts, V.A., et al., The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit [see comments]. Nat Genet, 1998. 19(4): p. 340-7.
  137. Smart, S.L., et al., Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron, 1998. 20(4): p. 809-19.
  138. Erickson, J.C., K.E. Clegg, and R.D. Palmiter, Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y [see comments]. Nature, 1996. 381(6581): p. 415-21.
  139. Kash, S.F., et al., Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A, 1997. 94(25): p. 14060-5.
  140. Yamamoto, A., et al., Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci, 1998. 18(6): p. 2063-74.
  141. Martin, B., et al., Evidence for a multigenic system controlling methyl-beta-carboline-3- carboxylate (beta-CCM)-induced seizures. Behav Genet, 1994. 24(3): p. 285-97.
  142. Elmslie, F.V., et al., Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet, 1997. 6(8): p. 1329-34.
  143. Swinyard, E.A., Electrically induced convulsions, in Experimental Models of Epilepsy - A Manual for the Laboratory Worker, D.P. Purpura, et al., Editors. 1972, Raven Press: New York.
  144. Engstrom, F.L. and D.M. Woodbury, Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia, 1988. 29(4): p. 389-95.
  145. Ferraro, T.N., et al., Genetic influences on electrical seizure threshold. Brain Res, 1998. 813(1): p. 207-10.
  146. Loscher, W., et al., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res, 1991. 8(3): p. 171-89.
  147. White, H.S., Chemoconvulsants, in Neuropharmacology Methods in Epilepsy Research, S.L. Peterson and T.E. Albertson, Editors. 1998, CRC Press: Boca Raton.
  148. Skradski, S.L., H.S. White, and L.J. Ptacek, Genetic mapping of a locus (mass1) causing audiogenic seizures in mice. Genomics, 1998. 49(2): p. 188-92.
  149. Matagne, A. and H. Klitgaard, Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res, 1998. 31(1): p. 59-71.
  150. White, H.S., et al., The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. Adv Neurol, 1998. 76: p. 29-39.
  151. Dichter, M.A., Mechanisms of action of new antiepileptic drugs. Adv Neurol, 1998. 76: p. 1-9.
  152. Litchfield, J.R.J. and R. Wilcoxon, A simplified method of evaluating dose effect experiments. J Pharmacol, 1949. 96: p. 99-113.
  153. Hosford, D.A. and Y. Wang, Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures [see comments]. Epilepsia, 1997. 38(4): p. 408-14.
  154. Nakamoto, Y., S. Nakayama, and J. Suzuki, Cerebral uptake of [14C]deoxyglucose during the entire seizure and the recovery period in an El mouse. Epilepsy Res, 1990. 5(1): p. 43-8.
  155. Sokoloff, L., Measurement of local glucose utilization and its use in localization of functional activity in the central nervous system of animals and man. Recent Prog Horm Res, 1983. 39: p. 75-126.
  156. Morton, N.E., Genetic epidemiology of hearing loss. Ann. NY Acad Sci, 1991. 630: p. 16-31.
  157. Brown, S.D. and K.P. Steel, Genetic deafness--progress with mouse models. Hum Mol Genet, 1994. 3: p. 1453-1456.
  158. Steel, K.P., Inherited hearing defects in mice. Annu Rev Genet, 1995. 29: p. 675-701.
  159. Gibson, F., et al., A type VII myosin encoded by the mouse deafness gene shaker-1. Nature, 1995. 374(6517): p. 62-4.
  160. Liu, X.Z., et al., Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene [letter]. Nat Genet, 1997. 17(3): p. 268-269.
  161. Liu, X.Z., et al., Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet, 1997. 16(2): p. 188-190.
  162. Weil, D., et al., Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature, 1995. 374(6517): p. 60-1.
  163. Probst, F.J., et al., Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene [see comments]. Science, 1998. 280(5368): p. 1444-1447.
  164. Wang, A., et al., Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3 [see comments]. Science, 1998. 280(5368): p. 1447-51.
  165. Erkman, L., et al., Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature, 1996. 381(6583): p. 603-6.
  166. Vahava, O., et al., Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans [see comments]. Science, 1998. 279(5358): p. 1950-4.
  167. Petit, C., Genes responsible for human hereditary deafness: symphony of a thousand. Nat Genet, 1996. 14(4): p. 385-91.
  168. Van Camp, G. and R.J.H. Smith, Heredity Hearing Loss Homepage: http://dnalab-www.uia.ac.be/dnalab/hhh.
  169. Keats, B.J., et al., The deafness locus (dn) maps to mouse chromosome 19. Mamm Genome, 1995. 6(1): p. 8-10.
  170. Deol, M.S., The anatomy and development of the mutants pirouette, shaker-1 and waltzer in the mouse. Proc R Soc Lond B Biol Sci, 1956. 145: p. 206-213.
  171. Zheng, Q.Y., K.R. Johnson, and L.C. Erway, Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hearing Research, 1999. in press.
  172. Johnson, K.R., S.A. Cook, and Q.Y. Zheng, The original shaker-with-syndactylism mutation (sy) is a contiguous gene deletion syndrome [In Process Citation]. Mamm Genome, 1998. 9(11): p. 889-892.
  173. Johnson, K.R., et al., Inner ear and kidney anomalies caused by IAP insertion in an intron of the Eya1 gene in a mouse model of BOR syndrome. Human Molecular Genetics, 1999. 8(4): p. 645-653.
  174. Johnson, K.R., et al., A major gene affecting age-related hearing loss in C57BL/6J mice. Hear Res, 1997. 114(1-2): p. 83-92.
  175. Noben-Trauth, K., et al., mdfw: A deafness susceptibility locus that interacts with deaf waddler (dfw). Genomics, 1997. 44: p. 266-272.
  176. Ikeda, A., et al., Genetic modification of hearing in tubby mice: evidence for the existence of a major gene (moth1) which protects tubby mice from hearing loss. Hum Mol Genet, 1999. 8(9): p. 1761-1767.
  177. Markand, O.N., Brainstem auditory evoked potentials. J Clin Neurophysiol, 1994. 11(3): p. 319-42.
  178. Moller, A.R., Auditory neurophysiology. J Clin Neurophysiol, 1994. 11(3): p. 284-308.
  179. Stockard, J.J. and V.S. Rossiter, Clinical and pathologic correlates of brain stem auditory response abnormalities. Neurology, 1977. 27(4): p. 316-25.
  180. Henry, K.R. and M.D. McGinn, The mouse as a model for human audition. A review of the literature. Audiology, 1992. 31(4): p. 181-189.
  181. Erway, L.C., et al., Genetics of age-related hearing loss in mice: I. Inbred and F1 hybrid strains. Hear. Res., 1993. 65: p. 125-132.
  182. Willott, J.F., et al., Genetics of age-related hearing loss in mice: II. Strain differences and effects of caloric restrictions on cochlear pathology and evoked response thresholds. Hearing Research, 1995. 88: p. 143-155.
  183. Erway, L.C., et al., Genetics of age-related hearing loss in mice. III. Susceptibility of inbred and F1 hybrid strains to noise-induced hearing loss. Hearing Research, 1996. 93: p. 181-187.
  184. Online Mendelian Inheritance in Man Database (OMIM): http://www3.ncbi.nlm.nih.gov/Omim/.
  185. Trauboulsi, E.I., Genetic Diseases of the Eye. 1999, Oxford: Oxford University Press.
  186. Travis, G.H., et al., Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature, 1989. 338(6210): p. 70-3.
  187. Pittler, S.J. and W. Baehr, Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A, 1991. 88(19): p. 8322-6.
  188. Bowes, C., et al., Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad Sci U S A, 1993. 90(7): p. 2955-9.
  189. Kajiwara, K., et al., Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature, 1991. 354(6353): p. 480-3.
  190. McLaughlin, M.E., et al., Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet, 1993. 4(2): p. 130-4.
  191. Chang, G.Q., Y. Hao, and F. Wong, Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron, 1993. 11(4): p. 595-605.
  192. National Society to Prevent Blindness, Vision Problems in the U.S. Data analysis, definitions, data sources, detailed data tables, analyses, interpretation. 1980, New York: National Society to Prevent Blindness.
  193. The Jackson Laboratory's Mouse Genome Database: http://www.informatics.jax.org/userdocs/aboutMGD.shtml.
  194. Heckenlively, J.R., et al., Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci U S A, 1995. 92(24): p. 11100-4.
  195. Roderick, T.H., et al., A new dominant retinal degeneration (Rd4) associated with a chromosomal inversion in the mouse. Genomics, 1997. 42(3): p. 393-6.
  196. Ikeda, S., et al., Retinal degeneration but not obesity is observed in null mutants of the tubby-like protein 1 gene. Hum. Molec. Genet., in press.
  197. Hawes, N.L., et al., Mouse fundus photography and angiography: A catalogue of normal and mutant phenotypes [In Process Citation]. Mol Vis, 1999. 5: p. 22.
  198. John, S.W., et al., Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci, 1997. 38(1): p. 249-53.
  199. John, S.W., et al., Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice [published erratum appears in Invest Ophthalmol Vis Sci 1998 Aug;39(9):1641]. Invest Ophthalmol Vis Sci, 1998. 39(6): p. 951-62.
  200. Smith, R.S., et al., Corn1: a mouse model for corneal surface disease and neovascularization. Invest Ophthalmol Vis Sci, 1996. 37(2): p. 397-404.
  201. Pardue, M.T., et al., A naturally occurring mouse model of X-linked congenital stationary night blindness. Invest Ophthalmol Vis Sci, 1998. 39(12): p. 2443-9.
  202. Weng, J., et al., Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell, 1999. 98(1): p. 13-23.
  203. Ikeda, S., et al., Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice. Invest Ophthalmol Vis Sci, 1999. 40(8): p. 1874-8.
  204. Rice, D.S., et al., Decreased retinal ganglion cell number and misdirected axon growth associated with fissure defects in Bst/+ mutant mice. Invest Ophthalmol Vis Sci, 1997. 38(10): p. 2112-24.
  205. Maren, S., Neurotoxic or electrolytic lesions of the ventral subiculum produce deficits in the acquisition and expression of Pavlovian fear conditioning in rats. Behav Neurosci, 1999. 113(2): p. 283-90.
  206. McAllister, W.R. and D.E. McAllister, Behavioral measurements of conditioned fear, in Aversive Conditioning and Learning, F.R. Brush, Editor. 1971, Academic Press: New York.
  207. Brown, J.S., H.I. Kalish, and I.E. Farber, Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. Journal of Experimental Psychology, 1951. 41: p. 317-328.
  208. Davis, M. and D.I. Astrachan, Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J Exp Psychol Anim Behav Process, 1978. 4(2): p. 95-103.
  209. Grillon, C., et al., Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology, 1990(28): p. 588-595.
  210. Grillon, C., et al., Safety signals and human anxiety: a fear-potentiated startle study. Anxiety, 1994. 1(1): p. 13-21.
  211. Falls, W.A., et al., Fear-potentiated startle in two strains of inbred mice. Behav Neurosci, 1997. 111(4): p. 855-61.
  212. Willott, J.F., S. Carlson, and H. Chen, Prepulse inhibition of the startle response in mice: relationship to hearing loss and auditory system plasticity. Behav Neurosci, 1994. 108(4): p. 703-13.
  213. Glowa, J.R. and C.T. Hansen, Differences in response to an acoustic startle stimulus among forty-six rat strains. Behav Genet, 1994. 24(1): p. 79-84.
  214. Grillon, C. and M. Davis, Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training. Psychophysiology, 1997. 34(4): p. 451-8.
  215. Hoffman, H.S. and J.R. Ison, Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev, 1980. 87(2): p. 175-89.
  216. Davis, M., et al., Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res, 1993. 58(1-2): p. 175-98.
  217. Caldarone, B., et al., Quantitative trait loci analysis affecting contextual conditioning in mice [see comments]. Nat Genet, 1997. 17(3): p. 335-7.
  218. Owen, E.H., et al., Identification of quantitative trait loci involved in contextual and auditory-cued fear conditioning in BXD recombinant inbred strains. Behav Neurosci, 1997. 111(2): p. 292-300.
  219. Owen, E.H., et al., Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience, 1997. 80(4): p. 1087-99.
  220. Paylor, R., et al., DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav Neurosci, 1994. 108(4): p. 810-7.
  221. Wehner, J.M., et al., Quantitative trait locus analysis of contextual fear conditioning in mice [see comments]. Nat Genet, 1997. 17(3): p. 331-4.
  222. Heldt, S.A. and W.A. Falls, Post-training lesions of the Amygdala interfere with fear-potentiated startle to both visual and auditory conditioned stimuli in C57BL/6J mice. Submitted.
  223. Bourtchuladze, R., et al., Deficient long-term memory in mice with a targeted mutation of the cAMP- responsive element-binding protein. Cell, 1994. 79(1): p. 59-68.
  224. Kogan, J.H., et al., Spaced training induces normal long-term memory in CREB mutant mice. Curr Biol, 1997. 7(1): p. 1-11.
  225. Fanselow, M.S. and R.C. Bolles, Naloxone and shock-elicited freezing in the rat. J Comp Physiol Psychol, 1979. 93(4): p. 736-44.
  226. Maren, S., Overtraining does not mitigate contextual fear conditioning deficits produced by neurotoxic lesions of the basolateral amygdala. J Neurosci, 1998. 18(8): p. 3088-97.
  227. Maren, S., G. Aharonov, and M.S. Fanselow, Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res, 1997. 88(2): p. 261-74.
  228. Mombaerts, P., Odorant receptor genes in humans. Curr Opin Genet Dev, 1999. 9(3): p. 315-320.
  229. Wysocki, C.J., Neurobehavioral evidence for the involvement of the vomeronasal system in mammalian reproduction. Neurosci Biobehav Rev, 1979. 3(4): p. 301-41.
  230. Preti, G. and C.J. Wysocki, Human pheromones: releasers or primers - fact or myth, in Advances in Chemical Signals in Vertebrates, R.E. Johnston, D. Muller-Schwarze, and P.W. Sorensen, Editors. 1999, Plenum Press: New York. p. 315-331.
  231. Keverne, E.B., et al., Non-olfactory chemoreceptors of the nose: some recent advances in understanding the vomeronasal and trigeminal systems. Chemical Senses, 1986. 11: p. 119-133.
  232. Wysocki, C.J., B.J. Cowart, and T. Radil, Localizing inhaled stimuli: a normative study of nasal-trigeminal chemosensitivity. Perception & Psychophysics, in press.
  233. Muller-Schwarze, D., N.J. Volkman, and K.F. Zemanek, Osmetrichia: specialized scent hair in black-tailed deer. J Ultrastruct Res, 1977. 59: p. 223-30.
  234. Johnston, R.E., D. Muller-Schwarze, and P.W. Sorensen, Advances in Chemical Signals in Vertebrates. 1999, New York: Plenum Press.
  235. Wysocki, C.J., G. Whitney, and D. Tucker, Specific anosmia in the laboratory mouse. Behav Genet, 1977. 7(2): p. 171-88.
  236. Wysocki, C.J. and G.K. Beauchamp, Ability to smell androstenone is genetically determined. Proc Natl Acad Sci U S A, 1984. 81: p. 4899-902.
  237. Rawson, N.E., et al., Selectivity and response characteristics of human olfactory neurons. J Neurophysiol, 1997. 77(3): p. 1606-13.
  238. Voznessenskaya, V.V., et al., Long lasting effects of chemical exposures in mice, in Advances in Chemical Signals in Vertebrates, R.E. Johnston, D. Muller-Schwarze, and P.W. Sorensen, Editors. 1999.
  239. Ninomiya, Y.N., et al, Taste receptor mechanisms influenced by a gene on chromosome 4 in mice. Genetics of Perception and Communication, 1991. 3: p. 267-278.
  240. Capeless, C.G., G. Whitney, and E.A. Azen, Chromosome mapping of Soa, a gene influencing gustatory sensitivity to sucrose octaacetate in mice. Behav Genet, 1992. 22(6): p. 655-63.
  241. Wong, G.T., K.S. Gannon, and R.F. Margolskee, Transduction of bitter and sweet taste by gustducin [see comments] [published erratum appears in Nature 1996 Oct 10;383(6600):557]. Nature, 1996. 381(6585): p. 796-800.
  242. Bachmanov, A.A., et al., Sucrose consumption in mice: major influence of two genetic loci affecting peripheral sensory responses. Mamm Genome, 1997. 8(8): p. 545-8.
  243. Blizard, D.A., B. Kotlus, and M.E. Frank, Quantitative trait loci associated with short-term intake of sucrose, saccharin and quinine solutions in laboratory mice. Chem Senses, 1999. 24(4): p. 373-85.
  244. Brunet, L.J., G.H. Gold, and J. Ngai, General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel. Neuron, 1996. 17(4): p. 681-93.
  245. Kiefer, S.W., K.G. Hill, and H.J. Kaczmarek, Taste reactivity to alcohol and basic tastes in outbred mice. Alcohol Clin Exp Res, 1998. 22(5): p. 1146-51.
  246. Brosvic, G.M. and B.M. Slotnick, Absolute and intensity-difference taste thresholds in the rat: evaluation of an automated multi-channel gustometer. Physiol Behav, 1986. 38(5): p. 711-7.
  247. Spector, A.C., J. Andrews-Labenski, and F.C. Letterio, A new gustometer for psychophysical taste testing in the rat. Physiol Behav, 1990. 47(4): p. 795-803.
  248. Reilly, S., R. Norgren, and T.C. Pritchard, A new gustometer for testing taste discrimination in the monkey. Physiol Behav, 1994. 55(3): p. 401-6.
  249. Bachmanov, A.A., M.G. Tordoff, and G.K. Beauchamp, Ethanol consumption and taste preferences in C57BL/6ByJ and 129/J mice. Alcoholism: Clinical and Experimental Research, 1996. 20: p. 201-206.
  250. Beauchamp, G.K. and A.S. Fisher, Strain differences in consumption of saline solutions by mice. Physiol Behav, 1993. 54(1): p. 179-84.
  251. Ninomiya, Y., et al., Qualitative discrimination of gustatory stimuli in three different strains of mice. Brain Res, 1984. 322(1): p. 83-92.
  252. Krimm, R.F. and I.J. Miller, Taste buds of the foliate and fungiform papilla compared for two strains of mice. Chemical Senses, 1989. 14: p. 719-720.
  253. Bachmanov, A.A., et al., Modification of behavioral and neural taste responses to NaCl in C57BL/6 mice: effects of NaCl exposure and DOCA treatment. Physiol Behav, 1999. 65(4-5): p. 817-22.
  254. Crabbe, J.C., et al., Genetic determinants of sensitivity to ethanol in inbred mice. Behav Neurosci, 1994. 108(1): p. 186-95.
  255. Crabbe, J.C., et al., Polygenic and single-gene determination of responses to ethanol in BXD/Ty recombinant inbred mouse strains. Neurobehav Toxicol Teratol, 1983. 5(2): p. 181-7.
  256. Tubbiola, M.L. and C.J. Wysocki, FOS immunoreactivity after exposure to conspecific or heterospecific urine: where are chemosensory cues sorted? Physiol Behav, 1997. 62(4): p. 867-70.
  257. Eppig, J.T. and M. Strivens, Finding a mouse: the International Mouse Strain Resource (IMSR). Trends Genet, 1999. 15(2): p. 81-2.
  258. Kohrman et al., Mutation detection in the med and medJ alleles of the sodium channel Scn8a. Unusual splicing due to a minor class AT-AC intron.
    (1996) J. Biol. Chem. 271(29):17576-81
  259. Yang Y., Beyer B.J., Otto J.F., O'Brien T.P., Letts V.A., White H. S., and Frankel W.N., Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold, Human Molecular Genetics, 2003. 12(9) p. 1-10.